Edwards Lifesciences (EW) News Today $69.77 -0.09 (-0.13%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Seilern Investment Management Ltd Invests $109.49 Million in Edwards Lifesciences Co. (NYSE:EW)Seilern Investment Management Ltd purchased a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,478,989 shares of the medical research company's stock, valued at appJanuary 20 at 6:37 AM | marketbeat.comDiversify Wealth Management LLC Acquires 18,715 Shares of Edwards Lifesciences Co. (NYSE:EW)Diversify Wealth Management LLC increased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 99.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 37,441 shares of the medical research comJanuary 20 at 6:22 AM | marketbeat.comGateway Investment Advisers LLC Raises Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Gateway Investment Advisers LLC boosted its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 97.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 11,581 shares of the medical research company's stock after acquiring anJanuary 19 at 3:40 AM | marketbeat.com65,442 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by Avanza Fonder ABAvanza Fonder AB purchased a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund purchased 65,442 shares of the medical research company's stock, valued at approximately $4,845,000. A number of other large inveJanuary 18 at 5:36 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Sees Significant Growth in Short InterestEdwards Lifesciences Co. (NYSE:EW - Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 11,310,000 shares, a growth of 54.9% from the December 15th total of 7,300,000 shares. Currently, 2.0% of the company's stock are short sold. Based on an average trading volume of 5,040,000 shares, the days-to-cover ratio is currently 2.2 days.January 17 at 9:05 PM | marketbeat.comBoston Common Asset Management LLC Lowers Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Boston Common Asset Management LLC lessened its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 26.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 152,532 shares of the medical research company's stock afterJanuary 17 at 10:05 AM | marketbeat.comDaniel J. Lippis Sells 500 Shares of Edwards Lifesciences Co. (NYSE:EW) StockJanuary 17 at 7:09 AM | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) VP Sells $34,380.00 in StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Daniel J. Lippis sold 500 shares of the business's stock in a transaction on Thursday, January 16th. The stock was sold at an average price of $68.76, for a total transaction of $34,380.00. Following the sale, the vice president now owns 23,189 shares in the company, valued at $1,594,475.64. The trade was a 2.11 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.January 16, 2025 | marketbeat.comEdwards Lifesciences CVP Daniel Lippis sells $34,382 in stockJanuary 16, 2025 | msn.comEdwards Lifesciences downgraded to Underperform at Wolfe ResearchJanuary 16, 2025 | markets.businessinsider.comWest Coast Financial LLC Sells 9,846 Shares of Edwards Lifesciences Co. (NYSE:EW)West Coast Financial LLC lowered its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 133,367 shares of the medical research cJanuary 16, 2025 | marketbeat.comWolfe Research cuts Edwards Lifesciences stock rating to UnderperformJanuary 16, 2025 | msn.comEdwards Lifesciences downgraded at Wolfe on TAVR worriesJanuary 16, 2025 | msn.comDo You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)?January 16, 2025 | insidermonkey.comWolfe Research Downgrades Edwards Lifesciences (NYSE:EW) to UnderperformWolfe Research lowered shares of Edwards Lifesciences from a "peer perform" rating to an "underperform" rating and set a $60.00 price target on the stock. in a research note on Thursday.January 16, 2025 | marketbeat.comCiti Reaffirms Their Buy Rating on Edwards Lifesciences (EW)January 15, 2025 | markets.businessinsider.comBernstein Reaffirms Their Hold Rating on Edwards Lifesciences (EW)January 15, 2025 | markets.businessinsider.comEdwards Lifesciences Co. (NYSE:EW) Position Boosted by Assenagon Asset Management S.A.Assenagon Asset Management S.A. boosted its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 475.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,243,976 shares of the medical research cJanuary 15, 2025 | marketbeat.comWELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST Has $355.34 Million Position in Edwards Lifesciences Co. (NYSE:EW)WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST raised its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,800,000 shares of the meJanuary 13, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Receives $79.40 Consensus Target Price from AnalystsJanuary 12, 2025 | americanbankingnews.comWhat is Zacks Research's Estimate for EW FY2024 Earnings?January 12, 2025 | americanbankingnews.comWhat is Zacks Research's Forecast for EW FY2024 Earnings?Edwards Lifesciences Co. (NYSE:EW - Free Report) - Equities research analysts at Zacks Research upped their FY2024 EPS estimates for Edwards Lifesciences in a research note issued on Tuesday, January 7th. Zacks Research analyst R. Department now anticipates that the medical research company willJanuary 10, 2025 | marketbeat.comZacks Research Has Strong Forecast for EW FY2025 EarningsJanuary 10, 2025 | americanbankingnews.comEdwards Lifesciences’ Q4 2024 Earnings: What to ExpectJanuary 9, 2025 | msn.comZacks Research Has Positive Outlook of EW FY2025 EarningsEdwards Lifesciences Co. (NYSE:EW - Free Report) - Stock analysts at Zacks Research raised their FY2025 EPS estimates for Edwards Lifesciences in a research report issued on Tuesday, January 7th. Zacks Research analyst R. Department now forecasts that the medical research company will post earninJanuary 9, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Receives Consensus Rating of "Hold" from AnalystsShares of Edwards Lifesciences Co. (NYSE:EW - Get Free Report) have been assigned a consensus recommendation of "Hold" from the twenty-six analysts that are presently covering the firm, MarketBeat Ratings reports. Fifteen investment analysts have rated the stock with a hold rating and eleven have gJanuary 9, 2025 | marketbeat.comEdwards Lifesciences price target raised to $74 from $72 at BernsteinJanuary 8, 2025 | markets.businessinsider.comBath Savings Trust Co Sells 32,577 Shares of Edwards Lifesciences Co. (NYSE:EW)Bath Savings Trust Co lessened its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 62.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 19,977 shares of the medical research company's stock after selling 32,577 shares during the period. BJanuary 7, 2025 | marketbeat.comEdwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | businesswire.comEdwards Lifesciences Corporation (NYSE:EW) is largely controlled by institutional shareholders who own 85% of the companyJanuary 6, 2025 | finance.yahoo.comEdwards Lifesciences Co. (NYSE:EW) Shares Acquired by Nordea Investment Management ABNordea Investment Management AB boosted its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 34.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 4,057,013 shares of the medical research company's stock after purchasing an additional 1January 6, 2025 | marketbeat.comEdward Lifesciences: A Closer Look At Growth And ValuationJanuary 5, 2025 | seekingalpha.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Edwards Lifesciences Corporation (EW)January 4, 2025 | markets.businessinsider.comEdwards Lifesciences price target raised to $75 from $69 at Evercore ISIJanuary 2, 2025 | markets.businessinsider.comEdwards Lifesciences (NYSE:EW) Shares Cross Above 200 Day Moving Average - Should You Sell?Edwards Lifesciences (NYSE:EW) Share Price Passes Above 200-Day Moving Average - Should You Sell?December 31, 2024 | marketbeat.comEdwards Lifesciences Corporation (EW): Among the Cheap Healthcare Stocks to Buy Heading Into 2025December 28, 2024 | insidermonkey.comEdwards Lifesciences Corp. stock remains steady Monday, underperforms marketDecember 23, 2024 | marketwatch.comPrincipal Financial Group Inc. Has $53.95 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW)Principal Financial Group Inc. grew its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 817,516 shares of the medical research company's stock after pDecember 23, 2024 | marketbeat.comJim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?December 20, 2024 | insidermonkey.comEdwards Lifesciences: Competitive Pressures and Valuation Concerns Lead to Sell RatingDecember 18, 2024 | markets.businessinsider.comDeutsche Bank Sticks to Its Buy Rating for Edwards Lifesciences (EW)December 18, 2024 | markets.businessinsider.comAssessing Edwards Lifesciences: Insights From 20 Financial AnalystsDecember 17, 2024 | benzinga.comB of A Securities Upgrades Edwards Lifesciences (EW)December 17, 2024 | msn.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Franklin Resources Inc.Franklin Resources Inc. boosted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,196,059 shares of the meDecember 17, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) VP Daniel J. Lippis Sells 2,500 SharesDecember 17, 2024 | insidertrades.comMML Investors Services LLC Has $2.25 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)MML Investors Services LLC decreased its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 65.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 34,115 shares of the medical research company's stocDecember 17, 2024 | marketbeat.comDaniel J. Lippis Sells 2,500 Shares of Edwards Lifesciences Co. (NYSE:EW) StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Daniel J. Lippis sold 2,500 shares of the business's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $74.08, for a total value of $185,200.00. Following the sale, the vice president now owns 23,189 shares in the company, valued at $1,717,841.12. The trade was a 9.73 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.December 16, 2024 | marketbeat.comEdwards Lifesciences upgraded to Buy from Neutral at BofADecember 16, 2024 | markets.businessinsider.comBank of America Upgrades Edwards Lifesciences (NYSE:EW) to "Buy"Bank of America upgraded shares of Edwards Lifesciences from a "neutral" rating to a "buy" rating in a research note on Monday.December 16, 2024 | marketbeat.comZacks Research Analysts Increase Earnings Estimates for EWEdwards Lifesciences Co. (NYSE:EW - Free Report) - Stock analysts at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for shares of Edwards Lifesciences in a report issued on Wednesday, December 11th. Zacks Research analyst R. Department now forecasts that the medical resDecember 16, 2024 | marketbeat.com Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address EW Media Mentions By Week EW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼0.660.43▲Average Medical News Sentiment EW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼2020▲EW Articles Average Week Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Boston Scientific News Stryker News Medtronic News Becton, Dickinson and Company News IDEXX Laboratories News ResMed News DexCom News STERIS News Insulet News Hologic News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 1/20/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
